What are the 16 theatres at the Festival of Genomics and Biodata London?

The 16 theatres at the Festival each explore a different area of genomics and biodata, from AI, multi-omics and rare disease to cancer, population health, and clinical genomics.

Can I attend sessions in multiple theatres?

Yes, attendees can freely explore sessions across all 16 theatres depending on their interests and schedule.

Are the theatre sessions included in my free ticket?

Yes, all theatre sessions are included as part of the Festival’s free ticket offering.

Explore 8 Theaters Festival of Genomics Biodata & AI Boston

Your 2026 Theaters

Whether you’re working in research, industry or in clinical labs, time and money is tighter than ever. We want to make sure that you squeeze as much value as you can from every single theater session, so:

All speakers sign a speaker pledge ensuring they present concrete takeaways, actionable insights and ideas you can implement.
All attendees get on-demand access to all sessions in the weeks following The Festival, removing the frustration of not being able to be in 8 theaters at once.
Access to all theaters is free for those who qualify for a free Festival ticket. Find out if you qualify here.

Scroll down to find out more about what’s being covered in each theater. To see the full agenda, click here.

Innovation Stage

Day 1 explores how new innovations in NGS are transforming speed, scale, accuracy and cost and how new sequencing approaches unlock everything from population-scale studies to routine clinical use.

Day 2 focuses on advanced genome analysis, including peta-byte scale infrastructure and AI-driven variant interpretation.

AI in Drug Discovery Stage

The latest ways that AI/ML is applied across the discovery pipeline, from data-driven decision-making to target and candidate identification.

This theater will cover generative AI, predictive modelling, and new strategies for scaling beyond proof-of-concept to enterprise-wide deployment and building AI-ready organizations.

Multi-Omics Integration Stage

Data integration, harmonization, interpretation, and visualization remain critical challenges.

Explore strategies for integrating genomic, transcriptomic, proteomic, proteogenomic and other omics data, and how applying AI to uncover deeper biological insights can drive better discovery.

Single-Cell Stage

The latest in how single-cell technologies reveal cellular diversity, states and interactions missed by bulk analysis.

Plus, how to scale to millions of cells, develop better multi-modal assays & new single-cell approaches to transform disease understanding, target exploration and biomarker discovery.

Spatial Stage

Mapping molecular data in its native tissue context reveals new biological insights.

This theater will compare new spatial omics approaches, examine trade-offs in resolution, coverage, accuracy, and cost, and present detailed, data-rich case studies featuring complex diseases.

Cancer Omics Stage

Explore new approaches in tumor microenvironment mapping, pathway analysis, liquid biopsy, and minimal residual disease (MRD).

This track will highlight novel cancer biomarkers, advances in immunotherapy, and novel strategies to understand & overcome therapeutic resistance.

Biopharma Data Management Stage

Effective acquisition and integration of high-quality datasets has become a critical imperative.

This track explores new ways for how data is captured, structured, governed, secured and shared to support compliance, collaboration and scalable AI-driven innovation across the pipeline.

Epigenetics Stage

While the genome is static, the epigenome is dynamic; shaped by environment and behavior, influencing disease onset and progression.

This track will cover new advances in epigenetic biomarkers, diagnostics, and therapies, and explore how epigenetics is driving novel approaches in research and clinical innovation.